UCL | PharmaTimes

UCL researchers launch congenital muscular dystrophy research programme

Emily Kimber — Wed, 23 Apr 2025 11:16:58 +0000

The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK

Parkinson’s UK partners with UCL on phase II trial

Lucy Parsons — Mon, 26 Oct 2020 10:02:00 +0000

Trial will investigate chemotherapy drug to alleviate hallucinations in people with Parkinson’s

Corticosteroids boost survival rates for COVID-19 patients

Selina McKee — Fri, 04 Sep 2020 08:52:00 +0000

Four papers have been published reinforcing evidence that steroids can significantly improve the outcomes for those critically ill with the virus

Clinical research cut 87% at peak of pandemic

Selina McKee — Tue, 25 Aug 2020 08:25:00 +0000

The model suggests that just 13% of full-time academics would have been available to carry out research during the height of the pandemic

UCL start-up Novai raises £500,000 for AI tech

Selina McKee — Thu, 23 Jul 2020 09:28:00 +0000

The funds will be used to further developed tech that enables earlier detection of eye disease

UCLB, Apollo secure first licensing deal with US investment powerhouse

Selina McKee — Tue, 21 Jul 2020 08:30:00 +0000

Deerfield is partnering on the development of a novel gene therapy

Researchers develop AI tool able to predict cancer relapse

Selina McKee — Thu, 28 May 2020 09:39:00 +0000

Researchers are hopeful that this 'ground-breaking approach' could accelerate the prediction of which patients are more at risk of their disease returning

Scientists develop revolutionary tech to improve prostate cancer detection

Selina McKee — Wed, 12 Dec 2018 09:43:00 +0000

A ‘revolutionary’ new medical software able to pinpoint the area from which surgeons should take a biopsy to detect prostate cancer has been developed by NIHR supported researchers.

First Alzheimer’s drug from Eisai/UCL alliance to enter clinical trials

Selina McKee — Thu, 06 Dec 2018 10:13:00 +0000

The first drug candidate from Eisai and University College London (UCL)’s drug discovery collaboration is to enter Phase I clinical trials for Alzheimer’s disease (AD) early next year.

Lilly streams £5m into virtual lab pact with UCL, Imperial

Selina McKee — Fri, 07 Sep 2018 09:03:00 +0000

Imperial College London, UCL and Eli Lilly have formed an alliance that strives to transform medicines manufacturing in England.